therapy
Chronic treatment with montelukast can provide       additional control of symptoms during exercise, but inhaled beta2-agonists remain       first-line therapy for prophylaxis and treatment.
Chronic treatment with montelukast can provide       additional control of symptoms during exercise, but inhaled beta2-agonists remain       first-line  @SUBJECT$   @PREDICAT$   @OBJECT$  and treatment.